Gujarat Terce Laboratories share news, announcements and annual reports
BSE: 524314Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹42.95.
30 Oct: open ₹44.00, high ₹44.00, low ₹40.50
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹32 Cr3,856th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 15.35
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 12.61
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 3.29
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 25.8%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹0.45 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 31.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 25.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.13
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 14,931
Gujarat Terce Laboratories share news and announcements
525 announcements, routine notices left out, newest first. Page 4 of 11.
Aug 2022
5 Aug · Board meeting
1 Aug · Reg. 34 (1) Annual Report.
Jul 2022
27 Jul · Board meeting
Meeting on 5 Aug 2022: quarterly results7 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
May 2022
31 May · Corporate action
31 May · Disclosure Pursuant To Regulation 23(9) SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
30 May · Board meeting
21 May · Intimation For Change In Address Of Registrar And Share Transfer Agent (RTA)
19 May · Board meeting
Meeting on 30 May 2022: audited results12 May · Analysts
Apr 2022
20 Apr · Compliance Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On March 31, 2022.
14 Apr · Compliance Certificate For The Year Ended On March 31, 2022
8 Apr · Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 07 Apr · Shareholding for the Period Ended March 31, 2022
Shareholding Pattern for the Period Ended March 31, 2022. For more details, kindly Click ....
Mar 2022
17 Mar · Legal
Exchange has sought clarification from Gujarat Terce Laboratories Ltd on March 17, 2022 with reference to significant movement in price, in order to ensure that investors have latest ....
Jan 2022
24 Jan · Results
24 Jan · Results
17 Jan · Board meeting
Meeting on 24 Jan 2022: quarterly results5 Jan · Shareholding for the Period Ended December 31, 2021
Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....4 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Dec 2021
Oct 2021
29 Oct · Disclosure Pursuant To Regulation 23(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015
28 Oct · Management
20 Oct · Board meeting
Meeting on 28 Oct 2021: quarterly results7 Oct · Shareholding for the Period Ended September 30, 2021
Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....6 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
8 Sep · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....8 Sep · Meeting
7 Sep · Reg. 34 (1) Annual Report
Aug 2021
11 Aug · Reg. 34 (1) Annual Report
Jul 2021
23 Jul · Results
23 Jul · Results
15 Jul · Board meeting
Meeting on 23 Jul 2021: quarterly results